Prime Medicine PRME Payments to Acquire Short-Term Investments
Payments to Acquire Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's payments to acquire short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's payments to acquire short-term investments?
- Prime Medicine (PRME) reported payments to acquire short-term investments of $7.28M in Q1 2026.
- How has Prime Medicine's payments to acquire short-term investments changed year-over-year?
- Prime Medicine's payments to acquire short-term investments decreased by 84.9% year-over-year, from $48.32M to $7.28M.
- What is the long-term trend for Prime Medicine's payments to acquire short-term investments?
- Over 2 years (2022 to 2025), Prime Medicine's payments to acquire short-term investments has grown at a 29.1% compound annual growth rate (CAGR), from $123.34M to $205.41M.